Maravai Lifesciences Holdings Ratios (2020-2025) | MRVI

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 69.99%54.81%77.51%76.21%78.82%82.64%84.27%82.87%83.61%84.55%80.04%73.99%57.39%37.21%45.13%52.65%40.27%44.42%46.70%34.28%16.49%16.39%13.58%
EBT Margin 53.97%1.44%44.01%15.09%60.17%66.99%73.74%63.34%68.30%72.09%59.48%46.83%-5.72%-19.39%-30.75%885.05%-34.92%-30.04%-249.39%-81.46%-112.47%-156.39%-108.45%
EBIT Margin 68.29%17.31%52.04%31.77%61.53%70.50%75.87%67.65%68.51%74.44%61.12%53.37%3.21%-16.85%-23.06%-9.64%-29.39%-19.36%-239.93%-66.66%-104.93%-139.84%-98.56%
EBITDA Margin 68.29%17.31%52.04%31.77%61.53%70.50%75.87%67.65%68.51%74.44%61.12%53.37%3.21%-16.85%-23.06%-9.64%-29.39%-19.36%-239.93%-66.66%-104.93%-139.84%-98.56%
Operating Margin 68.29%17.31%52.04%31.77%61.53%70.50%75.87%67.65%68.51%74.44%61.12%53.37%3.21%-16.85%-23.06%-9.64%-29.39%-19.36%-239.93%-66.66%-104.93%-139.84%-98.56%
Net Margin 46.84%3.07%44.42%14.71%50.92%61.76%64.54%55.64%60.12%64.57%52.10%42.71%-1.71%-17.33%-22.59%-148.34%-35.34%-26.53%-249.84%-81.45%-112.81%-147.34%-108.23%
FCF Margin 12.37%18.24%47.05%71.76%23.61%74.12%50.89%23.24%65.31%66.99%54.16%45.49%97.70%-8.51%-2.48%-12.15%-22.02%11.35%6.58%-36.22%-31.22%-27.72%-43.42%
Efficiency
Inventory Average 0.04B0.05B0.05B0.05B0.05B0.06B0.06B0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.05B
Assets Average 1.31B1.48B1.75B1.91B1.98B2.11B2.21B2.27B2.30B2.29B2.27B1.88B1.47B1.44B1.36B1.14B0.98B0.93B0.87B
Equity Average 0.18B0.27B0.39B0.50B0.60B0.71B0.81B0.87B0.90B0.90B0.89B0.84B0.78B0.77B0.69B0.59B0.55B0.50B0.45B
Invested Capital 0.69B0.74B0.87B0.99B1.08B1.18B1.30B1.37B1.43B1.43B1.42B1.42B1.31B1.30B1.30B1.13B0.87B0.83B0.76B0.72B
Asset Utilization Ratio 0.290.370.380.420.450.440.410.390.310.240.190.150.190.190.200.230.250.240.22
Leverage & Solvency
Interest Coverage Ratio 4.721.096.453.5511.5420.0720.2222.0162.8340.7537.2810.730.21-1.65-1.32-0.46-1.74-1.13-12.15-3.35-7.25-9.73-6.00
Debt to Equity 3.452.541.601.651.371.140.960.890.580.800.590.590.660.670.680.850.510.560.630.68
Debt Ratio 0.420.390.330.400.390.370.340.330.230.310.230.230.350.360.360.410.290.310.330.34
Equity Ratio 0.120.160.210.240.280.320.360.370.400.390.400.390.530.540.540.480.570.550.520.51
Times Interest Earned 4.721.096.453.5511.5420.0720.2222.0162.8340.7537.2810.730.21-1.65-1.32-0.46-1.74-1.13-12.15-3.35-7.25-9.73-6.00
Dividends & Payouts
FCF Payout Ratio 0.020.001.700.660.200.480.890.250.260.360.330.11-0.220.070.00
Valuation
Enterprise Value 7.30B9.42B10.89B9.68B10.29B9.27B7.57B6.85B3.43B3.89B2.92B2.30B1.74B1.98B1.56B1.79B1.30B0.51B0.55B0.68B
Market Capitalization 7.23B9.32B10.75B9.52B10.06B9.00B7.25B6.52B3.70B3.51B3.12B2.51B1.94B2.18B1.80B2.10B1.38B0.56B0.61B0.73B
Return Ratios
Return on Sales 0.28%0.34%0.48%0.53%0.59%0.60%0.61%0.58%0.56%0.48%0.32%0.14%-0.48%-0.58%-0.61%-1.17%-1.00%-1.20%-1.55%-1.11%
Return on Capital Employed 0.15%0.25%0.26%0.31%0.33%0.33%0.30%0.27%0.19%0.10%0.04%-0.02%-0.04%-0.04%-0.16%-0.22%-0.29%-0.37%-0.24%
Return on Invested Capital 0.22%0.37%0.41%0.48%0.50%0.47%0.41%0.36%0.26%0.14%-0.23%-0.31%-0.40%-0.26%
Return on Assets 0.10%0.18%0.20%0.25%0.27%0.27%0.24%0.22%0.15%0.08%0.03%-0.07%-0.11%-0.12%-0.24%-0.23%-0.29%-0.37%-0.24%
Return on Equity 0.72%0.97%0.91%0.94%0.90%0.79%0.66%0.56%0.38%0.19%0.07%-0.16%-0.20%-0.21%-0.47%-0.44%-0.52%-0.68%-0.48%